P. Vantveer et al., DDT (DICOPHANE) AND POSTMENOPAUSAL BREAST-CANCER IN EUROPE - CASE-CONTROL STUDY, BMJ. British medical journal, 315(7100), 1997, pp. 81-85
Objective: To examine any possible links between exposure to DDE (1,1-
dichIoro-2,2-bis(p-chlorophenyl)ethylene), the persistent metabolite o
f the pesticide dicophane (DDT), and breast cancer. Design: Multicentr
e study of exposure to DDE by measurement of adipose tissue aspirated
from the buttocks. Laboratory measurements were conducted in a single
Laboratory. Additional data on risk factors for breast cancer were obt
ained by standard questionnaires. Setting: Centres in Germany, the Net
herlands, Northern Ireland, Switzerland, and Spain. Subjects: 265 post
menopausal women with breast cancer and 341 controls matched for age a
nd centre. Main outcome measure: Adipose DDE concentrations. Results:
Women with breast cancer had adipose DDE concentrations 9.2% lower tha
n control women. No increased risk of breast cancer was found at highe
r concentrations. The odds ratio of breast cancer, adjusted for age an
d centre, for the highest versus the lowest fourth of DDE distribution
was 0.73 (95% confidence interval 0.44 to 1.21) and decreased to 0.48
(0.25 to 0.95; P for trend = 0.02) after adjustment for body mass ind
ex, age at first birth, and current alcohol drinking. Adjustment for o
ther risk factors did not materially affect these estimates. Conclusio
ns: The lower DDE concentrations observed among the women with breast
cancer may be secondary to disease inception. This study does not supp
ort the hypothesis that DDE increases risk of breast cancer in postmen
opausal women in Europe.